FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer
Phase II Trial of Depsipeptide (NSC-630176) in Colorectal Cancer Patients Who Have Received Either One or Two Prior Chemotherapy Regimens for Metastatic or Locally Advanced, Unresectable Disease
2 other identifiers
interventional
N/A
1 country
88
Brief Summary
RATIONALE: Drugs used in chemotherapy, such as FR901228, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well FR901228 works in treating patients with unresectable locally advanced or metastatic colorectal cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2004
Shorter than P25 for phase_2 colorectal-cancer
88 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2004
CompletedFirst Posted
Study publicly available on registry
February 12, 2004
CompletedStudy Start
First participant enrolled
April 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2006
CompletedJune 24, 2013
November 1, 2005
February 10, 2004
June 21, 2013
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- SWOG Cancer Research Networklead
- National Cancer Institute (NCI)collaborator
Study Sites (88)
MBCCOP - Gulf Coast
Mobile, Alabama, 36607, United States
CCOP - Western Regional, Arizona
Phoenix, Arizona, 85006-2726, United States
Veterans Affairs Medical Center - Phoenix (Carl T. Hayden)
Phoenix, Arizona, 85012, United States
Veterans Affairs Medical Center - Tucson
Tucson, Arizona, 85723, United States
Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, 85724, United States
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
Veterans Affairs Medical Center - Little Rock
Little Rock, Arkansas, 72205, United States
City of Hope Comprehensive Cancer Center
Duarte, California, 91010-3000, United States
Veterans Affairs Medical Center - Loma Linda (Pettis)
Loma Linda, California, 92357, United States
USC/Norris Comprehensive Cancer Center and Hospital
Los Angeles, California, 90033, United States
Jonsson Comprehensive Cancer Center at UCLA
Los Angeles, California, 90095-1781, United States
Veterans Affairs Outpatient Clinic - Martinez
Martinez, California, 94553, United States
CCOP - Bay Area Tumor Institute
Oakland, California, 94609-3305, United States
Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
Orange, California, 92868, United States
CCOP - Santa Rosa Memorial Hospital
Santa Rosa, California, 95403, United States
University of Colorado Cancer Center at University of Colorado Health Sciences Center
Aurora, Colorado, 80010, United States
Veterans Affairs Medical Center - Denver
Denver, Colorado, 80220, United States
MBCCOP - Howard University Cancer Center
Washington D.C., District of Columbia, 20060, United States
Veterans Affairs Medical Center - Tampa (Haley)
Tampa, Florida, 33612, United States
CCOP - Atlanta Regional
Atlanta, Georgia, 30342-1701, United States
MBCCOP - Hawaii
Honolulu, Hawaii, 96813, United States
MBCCOP - University of Illinois at Chicago
Chicago, Illinois, 60612, United States
Veterans Affairs Medical Center - Chicago Westside Hospital
Chicago, Illinois, 60612, United States
CCOP - Central Illinois
Decatur, Illinois, 62526, United States
Veterans Affairs Medical Center - Hines
Hines, Illinois, 60141, United States
Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, 60153-5500, United States
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, 66160-7353, United States
CCOP - Wichita
Wichita, Kansas, 67214-3882, United States
Veterans Affairs Medical Center - Wichita
Wichita, Kansas, 67218, United States
Veterans Affairs Medical Center - Lexington
Lexington, Kentucky, 40502-2236, United States
Markey Cancer Center at University of Kentucky Chandler Medical Center
Lexington, Kentucky, 40536-0084, United States
MBCCOP - LSU Health Sciences Center
New Orleans, Louisiana, 70112, United States
Tulane Cancer Center at Tulane University Hospital and Clinic
New Orleans, Louisiana, 70112, United States
Veterans Affairs Medical Center - New Orleans
New Orleans, Louisiana, 70112, United States
Veterans Affairs Medical Center - Shreveport
Shreveport, Louisiana, 71101-4295, United States
Feist-Weiller Cancer Center at Louisiana State University Health Sciences
Shreveport, Louisiana, 71130-3932, United States
Cancer Research Center at Boston Medical Center
Boston, Massachusetts, 02118, United States
CCOP - Michigan Cancer Research Consortium
Ann Arbor, Michigan, 48106, United States
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109-0948, United States
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201-1379, United States
Veterans Affairs Medical Center - Detroit
Detroit, Michigan, 48201-1932, United States
Josephine Ford Cancer Center at Henry Ford Health System
Detroit, Michigan, 48202, United States
CCOP - Grand Rapids
Grand Rapids, Michigan, 49503, United States
CCOP - Beaumont
Royal Oak, Michigan, 48073-6769, United States
Providence Cancer Institute at Providence Hospital - Southfield Campus
Southfield, Michigan, 48075, United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216-4505, United States
Veterans Affairs Medical Center - Jackson
Jackson, Mississippi, 39216, United States
CCOP - Kansas City
Kansas City, Missouri, 64131, United States
CCOP - Cancer Research for the Ozarks
Springfield, Missouri, 65807, United States
Saint Louis University Cancer Center
St Louis, Missouri, 63110, United States
CCOP - St. Louis-Cape Girardeau
St Louis, Missouri, 63141, United States
CCOP - Montana Cancer Consortium
Billings, Montana, 59101, United States
Veterans Affairs Medical Center - Albuquerque
Albuquerque, New Mexico, 87108-5138, United States
MBCCOP - University of New Mexico HSC
Albuquerque, New Mexico, 87131, United States
NYU Cancer Institute at New York University Medical Center
New York, New York, 10016, United States
Herbert Irving Comprehensive Cancer Center at Columbia University
New York, New York, 10032, United States
James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, 14642, United States
CCOP - Southeast Cancer Control Consortium
Goldsboro, North Carolina, 27534-9479, United States
Veterans Affairs Medical Center - Cincinnati
Cincinnati, Ohio, 45220-2288, United States
Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio, 45267-0501, United States
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, 44195-9001, United States
CCOP - Columbus
Columbus, Ohio, 43206, United States
Veterans Affairs Medical Center - Dayton
Dayton, Ohio, 45428-1002, United States
CCOP - Dayton
Dayton, Ohio, 45429, United States
Oklahoma University Medical Center
Oklahoma City, Oklahoma, 73104, United States
Cancer Institute at Oregon Health and Science University
Portland, Oregon, 97201-3098, United States
CCOP - Columbia River Oncology Program
Portland, Oregon, 97225, United States
Veterans Affairs Medical Center - Charleston
Charleston, South Carolina, 29401-5799, United States
Hollings Cancer Center at Medical University of South Carolina
Charleston, South Carolina, 29425, United States
CCOP - Greenville
Greenville, South Carolina, 29615, United States
CCOP - Upstate Carolina
Spartanburg, South Carolina, 29303, United States
University of Tennessee Cancer Institute at Methodist Central Hospital
Memphis, Tennessee, 38104, United States
Veterans Affairs Medical Center - Memphis
Memphis, Tennessee, 38104, United States
Harrington Cancer Center
Amarillo, Texas, 79106, United States
Veterans Affairs Medical Center - Amarillo
Amarillo, Texas, 79106, United States
Brooke Army Medical Center
Fort Sam Houston, Texas, 78234-6200, United States
University of Texas Medical Branch
Galveston, Texas, 77555-0565, United States
M.D. Anderson Cancer Center at University of Texas
Houston, Texas, 77030-4095, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229-3900, United States
Veterans Affairs Medical Center - Temple
Temple, Texas, 76504, United States
CCOP - Scott and White Hospital
Temple, Texas, 76508, United States
Huntsman Cancer Institute at University of Utah
Salt Lake City, Utah, 84112-5550, United States
Veterans Affairs Medical Center - Salt Lake City
Salt Lake City, Utah, 84148, United States
Sentara Cancer Institute at Sentara Norfolk General Hospital
Norfolk, Virginia, 23510-1115, United States
CCOP - Virginia Mason Research Center
Seattle, Washington, 98101, United States
Veterans Affairs Medical Center - Seattle
Seattle, Washington, 98108, United States
Puget Sound Oncology Consortium
Seattle, Washington, 98109, United States
CCOP - Northwest
Tacoma, Washington, 98405-0986, United States
Related Publications (2)
Whitehead RP, Rankin C, Hoff PM, Gold PJ, Billingsley KG, Chapman RA, Wong L, Ward JH, Abbruzzese JL, Blanke CD. Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336). Invest New Drugs. 2009 Oct;27(5):469-75. doi: 10.1007/s10637-008-9190-8. Epub 2008 Oct 22.
PMID: 18941712RESULTWhitehead RP, McCoy S, Wollner IS, et al.: Phase II trial of depsipeptide (NSC-630176) in colorectal cancer patients who have received either one or two prior chemotherapy regimens for metastatic or locally advanced, unresectable disease: a Southwest Oncology Group study. [Abstract] American Society of Clinical Oncology 2006 Gastrointestinal Cancers Symposium, 26-28 January 2006, San Francisco, California. A-255, 2006.
RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
Robert P. Whitehead, MD
University of Texas
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Masking
- NONE
- Purpose
- TREATMENT
- Sponsor Type
- NETWORK
Study Record Dates
First Submitted
February 10, 2004
First Posted
February 12, 2004
Study Start
April 1, 2004
Study Completion
April 1, 2006
Last Updated
June 24, 2013
Record last verified: 2005-11